The Phase II project of the Feiman Bio Changchun Jingyue Factory, undertaken by the Group Company, has officially commenced.

Release time:

2026-04-29

The Phase II project of the Feiman Bio Changchun Jingyue Factory, undertaken by the Group Company, has officially commenced construction.

On April 28, a grand groundbreaking ceremony was held for the Phase II project of the Feiman Bio Changchun Jingyue Factory, which is being constructed by the Group. Zhang Jian, General Manager of the company, Xu Bing, Deputy General Manager, and other senior executives attended the ceremony.

This project is being developed under an engineering, procurement, and construction (EPC) contracting model, with a planned gross floor area exceeding 20,000 square meters and a contract value of more than RMB 200 million. Construction is being undertaken by the Group’s Jinhui Branch. Leveraging Feiman Bio’s technological breakthroughs in the field of active collagen, the project will establish a full-industry-chain ecosystem spanning research and development to production, with the aim of setting a benchmark for the biopharmaceutical industry. At the groundbreaking ceremony, General Manager Zhang Jian delivered a speech, stating that Jiangsu Qian’an will fully leverage its expertise in pharmaceutical infrastructure construction, honor its commitments through pragmatic action, and reciprocate the trust placed in it with uncompromising quality. Mr. Zhang urged the project team to spare no effort in creating greater value for the client, ensuring the project’s high-quality execution, and ushering in a new chapter of mutually beneficial cooperation between the two parties. The successful commencement ceremony marks the entry of Jiangsu Qian’an’s collaboration with Feiman Biotechnology into a new phase, while also underscoring Jiangsu Qian’an’s professional expertise and technological strengths in the pharmaceutical infrastructure sector. Moving forward, the two parties will leverage this project as a strategic link to further deepen their cooperation, jointly driving innovation and development in the biopharmaceutical and medical aesthetics industries, and contributing to regional economic growth and industry advancement. (Jinhui Branch)

Group Labor Service Company Holds 2026 Annual Labor Management Work Conference

The Group’s Pudong Airport West Cargo Area Integrated Energy Station Project Has Undergone Completion Acceptance and Been Delivered for Use.

Recommended news

2026-06-05

The Group’s Roche Pharmaceutical Project has been awarded the One-Million-Safety-Hours Award.

On June 5, the Roche (Shanghai) Biopharmaceutical Production Base Project (Phase I) held a ceremony to celebrate reaching one million safe man-hours, and the Group was presented with a commemorative trophy.

2026-05-26

The Group convened a special meeting of the dedicated task force for major project services.

On the afternoon of May 25, the Group convened a special working meeting on major project services in the 16th-floor conference room, with senior management and all members of the Major Project Management Department in attendance. The meeting was chaired by Zhang Jian, General Manager of the Group.

2026-05-26

The Jinshun Branch of the Group organized a project management observation and exchange event.

On May 23, the Jinshun Branch of the Group organized an on-site observation and exchange session on project management. All project managers, frontline supervisors, and relevant personnel from various functional departments of the branch attended the event, while selected managers from China State Construction Engineering Corporation Third Bureau and Xinjiang Production and Construction Corps Construction Engineering Company were invited to participate in the observation and discussion.

2026-05-09

Group General Manager Zhang Jian Visits Asahi Kasei (Nantong) to Deepen Cooperation and Exchange

On May 8, Zhang Jian, General Manager of the Group, led a delegation to Asahi Kasei Fine Chemicals (Nantong) Co., Ltd. for a project follow-up visit and exchange meeting, during which they held a symposium with Asahi Kasei General Manager Yuichi Sanro and other senior executives. Cai Ting and Gao Mingmin, Deputy General Managers of the Group, also attended the event.

2026-05-21

The Group has won the bid for the Fujian Yuanfu Technology project to produce 3,000 tons per year of high-purity lithium fluoride.

Recently, good news emerged from the southern market: the Group has successfully won the bid for Fujian Yuanfu Technology Co., Ltd.’s 3,000-ton-per-year high-purity lithium fluoride project under an EPC general contracting model, with a total contract value exceeding RMB 40 million.

2026-05-19

The Shanghai Wangyuan Building Hotel’s comprehensive renovation project has entered its final sprint.

In mid-May, the hotel renovation project for the Shanghai Wangyuan Building, undertaken by the Group, entered its final, critical phase of intensive completion. At present, all core construction tasks— including the main interior finishing works and the installation and commissioning of various mechanical and electrical systems—have been successfully completed. The project’s focus has now fully shifted to meticulous fine‑tuning, integrated system testing and commissioning, and comprehensive on‑site cleanup and final finishing.